Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5591762 | BOEHRINGER INGELHEIM | Benzimidazoles useful as angiotensin-11 antagonists |
Jan, 2014
(10 years ago) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Combination(NC) | Oct 16, 2012 |
Market Authorisation Date: 16 October, 2009
Treatment: Treatment of hypertension
Dosage: TABLET;ORAL